BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 30212968)

  • 1. Prognostic impact of preoperative anemia on upper tract urothelial carcinoma.
    Tan P; Xie N; Liao H; Zou L; Xu H; Yang L; Liu L; Wei Q
    Medicine (Baltimore); 2018 Sep; 97(37):e12300. PubMed ID: 30212968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Impact of Preoperative Albumin-Globulin Ratio on Oncologic Outcomes in Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy.
    Xu H; Tan P; Ai J; Huang Y; Lin T; Yang L; Wei Q
    Clin Genitourin Cancer; 2018 Oct; 16(5):e1059-e1068. PubMed ID: 29980449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity.
    Luo Y; Feng B; Wei D; Han Y; Li M; Zhao J; Lin Y; Hou Z; Jiang Y
    Sci Rep; 2020 Oct; 10(1):17674. PubMed ID: 33077839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma.
    Kim HS; Ku JH; Jeong CW; Kwak C; Kim HH
    World J Urol; 2016 Jun; 34(6):859-69. PubMed ID: 26497823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between lymphovascular invasion and oncological outcome in node-negative upper tract urothelial carcinoma with different stage.
    Chen CS; Lin CY; Wang CL; Wang SS; Li JR; Yang CK; Cheng CL; Chiu KY; Yang SF
    Urol Oncol; 2021 Feb; 39(2):132.e13-132.e26. PubMed ID: 32900630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Cha EK; Shariat SF; Kormaksson M; Novara G; Chromecki TF; Scherr DS; Lotan Y; Raman JD; Kassouf W; Zigeuner R; Remzi M; Bensalah K; Weizer A; Kikuchi E; Bolenz C; Roscigno M; Koppie TM; Ng CK; Fritsche HM; Matsumoto K; Walton TJ; Ehdaie B; Tritschler S; Fajkovic H; Martínez-Salamanca JI; Pycha A; Langner C; Ficarra V; Patard JJ; Montorsi F; Wood CG; Karakiewicz PI; Margulis V
    Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Rink M; Sharifi N; Fritsche HM; Aziz A; Miller F; Kluth LA; Ngamsri T; Dahlem R; Chun FK; Shariat SF; Stenzl A; Fisch M; Gakis G
    J Urol; 2014 Feb; 191(2):316-22. PubMed ID: 24036235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative positive voided urine cytology predicts poor clinical outcomes in patients with upper tract urothelial carcinoma undergoing nephroureterectomy.
    Liu W; Wang Z; Liu S; Yao Y; Liu Y; Zhang G
    BMC Cancer; 2020 Nov; 20(1):1113. PubMed ID: 33198698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy.
    Vartolomei MD; Mathieu R; Margulis V; Karam JA; Rouprêt M; Lucca I; Mbeutcha A; Seitz C; Karakiewicz PI; Fajkovic H; Wood CG; Weizer AZ; Raman JD; Rioux-Leclercq N; Haitel A; Bensalah K; Rink M; Briganti A; Xylinas E; Shariat SF
    World J Urol; 2017 Jan; 35(1):121-130. PubMed ID: 27209168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten-year survival outcomes after radical nephroureterectomy with a risk-stratified approach using prior diagnostic ureteroscopy: a single-institution observational retrospective cohort study.
    Veeratterapillay R; Geraghty R; Pandian R; Roy C; Stenhouse G; Bird C; Soomro N; Paez E; Rogers A; Johnson M; Page T; Rix D; Thomas D; Rai BP
    BJU Int; 2022 Jun; 129(6):744-751. PubMed ID: 34726325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of urokinase-type plasminogen activator system in upper tract urothelial carcinoma and its prognostic value after radical nephroureterectomy.
    Abufaraj M; Kimura S; Haitel A; Iwata T; Isleem U; D'Andrea D; Soria F; Mori K; Rink M; Bensalah K; Rouprêt M; Margulis V; Briganti A; Karakiewicz PI; Shariat SF
    Urol Oncol; 2020 Aug; 38(8):685.e17-685.e25. PubMed ID: 32381392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative Pyuria Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
    Sato G; Yoshida T; Yanishi M; Saito R; Murota T; Kawa G; Kinoshita H; Matsuda T
    Clin Genitourin Cancer; 2020 Apr; 18(2):e167-e173. PubMed ID: 31635939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is preoperative anemia a risk factor for upper tract urothelial carcinoma following radical nephroureterectomy?
    Yeh HC; Chien TM; Wu WJ; Li CC; Li WM; Ke HL; Chou YH; Wang CJ; Huang SP; Li CF; Liang PI; Huang CN
    Urol Oncol; 2016 Aug; 34(8):337.e1-9. PubMed ID: 27133951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interethnic differences in the impact of body mass index on upper tract urothelial carcinoma following radical nephroureterectomy.
    Yeh HC; Li CC; Chien TM; Li CY; Cheng YC; Woldu SL; Robyak H; Huang CN; Ke HL; Li WM; Lee HY; Yeh BW; Yang SF; Tu HP; Sagalowsky AI; Raman JD; Singla N; Margulis V; Lotan Y; Hsieh JT; Wu WJ
    World J Urol; 2021 Feb; 39(2):491-500. PubMed ID: 32318857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Rieken M; Xylinas E; Kluth L; Trinh QD; Lee RK; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Kautzky-Willer A; Bachmann A; Shariat SF;
    Eur J Surg Oncol; 2014 Jan; 40(1):113-20. PubMed ID: 24113620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upper Urinary Tract Urothelial Cancer After Radical Cystectomy for Bladder Cancer: Survival Outcomes After Radical Nephroureterectomy.
    Ślusarczyk A; Zapała P; Piecha T; Zapała Ł; Borkowski T; Radziszewski P
    Ann Surg Oncol; 2024 Mar; 31(3):2144-2153. PubMed ID: 38085392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of tumour size on prognosis of upper urinary tract urothelial carcinoma after radical nephroureterectomy: a multi-institutional analysis of 795 cases.
    Shibing Y; Liangren L; Qiang W; Hong L; Turun S; Junhao L; Lu Y; Zhengyong Y; Yonghao J; Guangqing F; Yunxiang L; Dehong C
    BJU Int; 2016 Dec; 118(6):902-910. PubMed ID: 26935344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic versus open nephroureterectomy to treat localized and/or locally advanced upper tract urothelial carcinoma: oncological outcomes from a multicenter study.
    Liu JY; Dai YB; Zhou FJ; Long Z; Li YH; Xie D; Liu B; Tang J; Tan J; Yao K; He LY
    BMC Surg; 2017 Jan; 17(1):8. PubMed ID: 28095848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the preoperative controlling nutritional status score as an independent predictor in a large Chinese cohort of patients with upper tract urothelial carcinoma.
    Xu H; Tan P; Jin X; Ai J; Lin T; Lei H; Yang L; Wei Q
    Cancer Med; 2018 Dec; 7(12):6112-6123. PubMed ID: 30485712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
    Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
    BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.